Figure 4.

Activation and death of CD8 T cells in a patient receiving three cycles of high dose scIL-2. Dying CD8⁺ T cells are activated. Values are percentage of CD8⁺ T cells that are CD38⁺ DR^Hi (diamonds) or that bind Annexin V (circles). Patient received 7.5 MIU scIL-2 on days 1–5, 57–61 and 114–118.